Lacock joins the company with over 26 years of experience, including significant tenures at Quest Diagnostics and CompuNet Clinical Laboratories. Her mandate is to drive commercial strategy and customer engagement as Alps Dx scales its connected approach to oral fluid testing. Her background in laboratory automation and strategic accounts is intended to support the company’s push into more complex, scalable testing environments.
The new facility at 1519 Summit Avenue serves as both an operational hub and an initial manufacturing site. It provides the necessary infrastructure for systems integration, assembly, and workflow testing. This expansion follows the earlier launch of the Alps Dx Atelier, a platform designed to automate preanalytical stages of fluid testing. By centralizing these capabilities, the company aims to move beyond manual, fragmented workflows toward a more integrated model across collection and analysis.
Comments (0)
No comments yet. Be the first!